Results 201 to 210 of about 91,337 (260)

Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model. [PDF]

Blood Adv
Dyer MR, Zheleznyak A, Teubner EN, Prior JL, Manion B, Jing Z, Sharma AK, Du J, Tang R, Fiala MA, DiPersio JF, Veis D, O'Neal J, Berezin MY, Shokeen M.   +14 more
europepmc   +1 more source

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]

J Immunol Res
Gnann DC, Steinke S, Garritsen HSP, Hust M.   +3 more
europepmc   +1 more source

Advances in the pathophysiology and treatment of anaemia in multiple myeloma. [PDF]

Curr Opin Hematol
Giuliani N, Dalla Palma B, Notarfranchi L.   +2 more
europepmc   +1 more source

Expression of CD38 on resting peripheral iNKT cells defines an immature subpopulation with distinct functionality in humans. [PDF]

Immunol Cell Biol
Menne C, Tavakolinia N, Perriman L, Moskorz W, Cosmovici C, Walker A, Olejnik L, Raba K, Du MR, Rossello FJ, Konstantinov IE, Berzins SP, Pellicci DG, Timm J.   +13 more
europepmc   +1 more source

Mechanisms of action and clinical development of elotuzumab [PDF]

, 2017
Colonna, Marco, Ritchie, David
core   +2 more sources

Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic Leukemia. [PDF]

Cancer Res Commun
Gravenmier C, Marzban S, Tang YH, Gillis N, Shah BD, Moscinski LC, Zhang L, West J.   +7 more
europepmc   +1 more source

V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia [PDF]

, 2003
Amlot, P, Duke, VM, Foroni, L, Gandini, D, Heelan, B, Hoffbrand, AV, Lin, K, Mehta, AB, Sherrington, PD   +8 more
core  

CD38 Expressing Cell Count [PDF]

, 2020
openaire   +1 more source

Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38⁺, CTLA-4⁺, and PD-1⁺ T and NK Cells. [PDF]

Neurol Neuroimmunol Neuroinflamm
Veeningen N, Añé-Kourí AL, Pues A, Rubio S, Fraussen J, Ioannou C, Martens DS, van Laake-Geelen CCM, Deckers J, Cornips EMJ, Bamps S, Gysemberg G, Van Broeckhoven J, Hellings N, Slaets H.   +14 more
europepmc   +1 more source

Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution. [PDF]

Discov Oncol
Mishra D, Patel A, Panjwani D, Patel S, Kushwaha N, Ahlawat P, Patel V.   +6 more
europepmc   +1 more source